Two possible cases of erenumab-induced xerostomia

Selvi-Sabater, P; Carvajal-Sanchez, MA; Carrera-Hueso, FJ

Selvi-Sabater, P (通讯作者),Murcia Hlth Serv, Pharm Serv, Murcia, Spain.;Carvajal-Sanchez, MA (通讯作者),Hosp Morales Meseguer, Pharm Serv, Murcia, Spain.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022; 47 (6): 824

Abstract

What is known and objective Erenumab is a monoclonal antibody for the prophylactic treatment of migraine. We describe the first cases of xerostomia pr......

Full Text Link